W.C. Kouns

814 total citations
17 papers, 718 citations indexed

About

W.C. Kouns is a scholar working on Hematology, Surgery and Immunology and Allergy. According to data from OpenAlex, W.C. Kouns has authored 17 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 8 papers in Surgery and 7 papers in Immunology and Allergy. Recurrent topics in W.C. Kouns's work include Platelet Disorders and Treatments (16 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Cell Adhesion Molecules Research (7 papers). W.C. Kouns is often cited by papers focused on Platelet Disorders and Treatments (16 papers), Heparin-Induced Thrombocytopenia and Thrombosis (8 papers) and Cell Adhesion Molecules Research (7 papers). W.C. Kouns collaborates with scholars based in Switzerland, United States and France. W.C. Kouns's co-authors include Beat Steiner, C F Fox, Lisa K. Jennings, Marijane White, Paul Hadváry, Leslie R. Ballou, Charles P. McKay, LK Jennings, Holger Schultz and Daniel Schlatter and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

W.C. Kouns

17 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.C. Kouns Switzerland 14 445 427 178 156 143 17 718
Daniel Snell United Kingdom 9 291 0.7× 81 0.2× 179 1.0× 38 0.2× 66 0.5× 14 516
Elisabeth Schaffner‐Reckinger Luxembourg 15 188 0.4× 287 0.7× 194 1.1× 50 0.3× 21 0.1× 30 566
Donogh P. O'Brien United Kingdom 12 1.1k 2.5× 36 0.1× 332 1.9× 93 0.6× 39 0.3× 19 1.4k
François Bourre France 10 100 0.2× 135 0.3× 261 1.5× 42 0.3× 19 0.1× 15 471
Bernd Muehlenweg Germany 14 123 0.3× 76 0.2× 232 1.3× 18 0.1× 26 0.2× 19 555
Steven King United States 3 54 0.1× 87 0.2× 288 1.6× 81 0.5× 20 0.1× 8 469
Juha Pekka Turunen Finland 14 31 0.1× 268 0.6× 300 1.7× 78 0.5× 50 0.3× 20 573
Rajeshwari R. Valiathan United States 8 24 0.1× 444 1.0× 313 1.8× 188 1.2× 19 0.1× 10 722
Laura Giuffrè Switzerland 11 56 0.1× 280 0.7× 279 1.6× 257 1.6× 20 0.1× 15 775
Nobuaki Akakura United States 7 63 0.1× 75 0.2× 328 1.8× 13 0.1× 40 0.3× 9 596

Countries citing papers authored by W.C. Kouns

Since Specialization
Citations

This map shows the geographic impact of W.C. Kouns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.C. Kouns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.C. Kouns more than expected).

Fields of papers citing papers by W.C. Kouns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.C. Kouns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.C. Kouns. The network helps show where W.C. Kouns may publish in the future.

Co-authorship network of co-authors of W.C. Kouns

This figure shows the co-authorship network connecting the top 25 collaborators of W.C. Kouns. A scholar is included among the top collaborators of W.C. Kouns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.C. Kouns. W.C. Kouns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Berchtold, Peter, Daniel J. Müller, W.C. Kouns, Markus A. Riederer, & Beat Steiner. (1998). Plasma autoantibodies against platelet glycoprotein IIb/IIIa from patients with autoimmune thrombocytopenic purpura may recognize different antigenic determinants. European Journal Of Haematology. 61(4). 223–228. 2 indexed citations
2.
Carroll, Roger C., Xiaofen Wang, François Lanza, Beat Steiner, & W.C. Kouns. (1997). Blocking Platelet Aggregation Inhibits Thromboxane A2 Formation by Low Dose Agonists But Does Not Inhibit Phosphorylation and Activation of Cytosolic Phospholipase A2. Thrombosis Research. 88(2). 109–125. 17 indexed citations
3.
Мазуров, А. В., С. Г. Хаспекова, Tatiana V. Byzova, et al.. (1996). Stimulation of platelet glycoprotein IIb‐IIIa (αIIbβ3‐integrin) functional activity by a monoclonal antibody to the N‐terminal region of glycoprotein IIIa. FEBS Letters. 391(1-2). 84–88. 25 indexed citations
4.
Berndt, MC, et al.. (1996). [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].. PubMed. 61(3). 412–28. 2 indexed citations
5.
Huber, Walter, et al.. (1995). Determination of Kinetic Constants for the Interaction Between the Platelet Glycoprotein IIb-IIIa and Fibrinogen by Means of Surface Plasmon Resonance. European Journal of Biochemistry. 227(3). 647–656. 43 indexed citations
6.
Huber, Walter, et al.. (1995). Determination of Kinetic Constants for the Interaction Between the Platelet Glycoprotein IIb‐IIIa and Fibrinogen by Means of Surface Plasmon Resonance. European Journal of Biochemistry. 227(3). 647–656. 43 indexed citations
7.
Satoh, T, W.C. Kouns, Y. Yamashita, Tsutomu Kamiyama, & Beat Steiner. (1994). Tetrafibricin Has a High Selectivity for GPIIb/IIIa: Comparison of the Effects of Tetrafibricin and RGDS on GPIIb/IIIa and the Vitronectin Receptor. Biochemical and Biophysical Research Communications. 204(1). 325–332. 13 indexed citations
8.
Satoh, T, W.C. Kouns, Y. Yamashita, Tsutomu Kamiyama, & Beat Steiner. (1994). Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa. Biochemical Journal. 301(3). 785–791. 14 indexed citations
9.
10.
Weller, Thomas, et al.. (1994). Fibrinogen receptor antagonists - a novel class of promising antithrombotics. Drugs of the Future. 19(5). 461–461. 38 indexed citations
11.
Steiner, Beat, et al.. (1993). Peptides derived from a sequence within beta 3 integrin bind to platelet alpha IIb beta 3 (GPIIb-IIIa) and inhibit ligand binding.. Journal of Biological Chemistry. 268(10). 6870–6873. 35 indexed citations
12.
Kouns, W.C., et al.. (1992). Conformational modulation of purified glycoprotein (GP) IIb-IIIa allows proteolytic generation of active fragments from either active or inactive GPIIb-IIIa.. Journal of Biological Chemistry. 267(26). 18844–18851. 61 indexed citations
13.
Rubinstein, Eric, W.C. Kouns, Lisa K. Jennings, Claude Boucheix, & Roger C. Carroll. (1991). Interaction of two GPIIb/IIIa monoclonal antibodies with platelet Fc receptor (FcγRII). British Journal of Haematology. 78(1). 80–86. 35 indexed citations
14.
Kouns, W.C. & Lisa K. Jennings. (1991). Activation-independent exposure of the GPIIb-IIIa fibrinogen receptor. Thrombosis Research. 63(3). 343–354. 22 indexed citations
15.
Kouns, W.C., C F Fox, William L’Amoreaux, Lewis B. Coons, & Lisa K. Jennings. (1991). The effect of glycoprotein IIb-IIIa receptor occupancy on the cytoskeleton of resting and activated platelets. Journal of Biological Chemistry. 266(21). 13891–13900. 53 indexed citations
16.
Jennings, LK, C F Fox, W.C. Kouns, et al.. (1990). The activation of human platelets mediated by anti-human platelet p24/CD9 monoclonal antibodies.. Journal of Biological Chemistry. 265(7). 3815–3822. 120 indexed citations
17.
Kouns, W.C., et al.. (1990). A conformation-dependent epitope of human platelet glycoprotein IIIa. Journal of Biological Chemistry. 265(33). 20594–20601. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Snell Breakdown of academic impact, for papers by Elisabeth Schaffner‐Reckinger Breakdown of academic impact, for papers by Donogh P. O'Brien Breakdown of academic impact, for papers by François Bourre Breakdown of academic impact, for papers by Bernd Muehlenweg Breakdown of academic impact, for papers by Steven King Breakdown of academic impact, for papers by Juha Pekka Turunen Breakdown of academic impact, for papers by Rajeshwari R. Valiathan Breakdown of academic impact, for papers by Laura Giuffrè Breakdown of academic impact, for papers by Nobuaki Akakura
Rankless by CCL
2026